TABLE 2.
Molecule | Object | Source | Expression | Potential target/mechanism | Results | References |
miR-19b miR-195,miR-24 |
Human | serum | Down Up |
Parkin RBR E3 ubiquitin protein ligase (miR-19b), LRRK2/PARK8 (miR-19b), and ATP13A2/PARK9 (miR-24 and miR-195). | ROC curve was used to evaluate the combined diagnostic value of the three miRNAs: AUC was 0.946 (95%CI, 0.910-0.981). | Cao et al., 2017 |
miR-153, miR-409-3p, miR-10a-5p, let-7g-3p miR-1 and miR-19b-3p |
Human | CSF | Up Down |
Neurotrophin signaling, mTOR signaling, Ubiquitin mediated proteolysis, Dopaminergic synapse, Glutamatergic synapse were the most prominent pathways | The sensitivity and specificity for distinguishing Parkinson’s disease from control were 94% for miR-1, 93% for miR-153, 90% for miR-409-3p, 94% for miR-19b-3p, 95% for miR-10a-5p, and 95% for let-7g-3p. | Gui et al., 2015 |
miR-505 miR-331-5p |
Human | serum | Down Up |
− | The ROC curve analysis AUC values of miRNA-331-5p and miR-505 were 0.849 and 0.898, respectively. | Yao et al., 2018 |
prion protein | Human | serum | Up | PrPC can increase phosphorylated α-synuclein and induce synaptic damage and calcium homeostasis. | The level of prion protein in PD plasma exosomes was significantly correlated with the level of cognitive impairment. (t = -3.185, P = 0.001) | Leng et al., 2020 |
DJ-1 | Human | serum | Up | DJ-1 can promote disease progression by regulating α-synuclein cytotoxicity. | The ROC analysis results of DJ-1 in PD plasma neurogenic exosomes were as follows: AUC = 0.703, sensitivity = 79.5%, specificity = 57.5%. | Zhao et al., 2018 |